Regen Lab SA

Regen Lab is a leading innovator of medical device in the field of products intended for autologous regenerative medicine, based on an extemporaneous preparation of Platelet-Rich Plasma (PRP, autologous thrombin…) from the patient’s blood, cell therapy (in particular extract MSCs from bone marrow) and combined therapy (PRP combined with hyaluronic acid).

The company invested in a new Good Manufacturing Practice facility located at the Mont-sur-Lausanne (Switzerland) beginning production in 2009.

To date, Regen Lab’s patented technologies are available in over 160 countries worldwide, and have been used to treat over 2 million patients in various therapeutic areas.